Stockscreener 앱 받기
3.08
9.61%
0.27
전일 마감가:
$2.81
열려 있는:
$2.8
하루 거래량:
9,038
Relative Volume:
0.17
시가총액:
$6.87M
수익:
$6,000
순이익/손실:
$-3.99M
주가수익비율:
-1.2498
EPS:
-2.4643
순현금흐름:
$-2.85M
1주 성능:
-2.22%
1개월 성능:
-29.36%
6개월 성능:
-5.23%
1년 성능:
+78.03%
1일 변동 폭
$2.80
$3.08
1주일 범위
$2.60
$3.19
52주 변동 폭
$1.3137
$6.20
Alaunos Therapeutics Inc Stock (TCRT) Company Profile
명칭
Alaunos Therapeutics Inc
전화
(346) 355-4099
주소
501 E LAS OLAS BLVD, FORT LAUDERDALE
TCRT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TCRT
Alaunos Therapeutics Inc
|
3.08 | 6.27M | 6,000 | -3.99M | -2.85M | -2.4643 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Alaunos Therapeutics Inc Stock (TCRT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-04 | 재개 | Wells Fargo | Overweight |
Alaunos Therapeutics Inc 주식(TCRT)의 최신 뉴스
Volume Report: Is BioSig Technologies Inc a turnaround storyJuly 2025 Review & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Downgrade Watch: Will Alaunos Therapeutics Inc benefit from rate cutsQuarterly Portfolio Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Why Alaunos Therapeutics Inc. stock could rally in 2025Trade Analysis Report & AI Driven Price Predictions - Улправда
Market Wrap: Why Alaunos Therapeutics Inc stock is favored by pension fundsJuly 2025 Final Week & AI Optimized Trade Strategies - Bộ Nội Vụ
Published on: 2026-01-09 20:19:14 - Улправда
Why Alaunos Therapeutics Inc. stock is seen as undervalued2025 Price Momentum & Verified High Yield Trade Plans - Улправда
Will Alaunos Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Gainers & Real-Time Buy Signal Notifications - Улправда
Why Alaunos Therapeutics Inc. stock remains on buy listsJuly 2025 Sentiment & Short-Term High Return Ideas - Улправда
Bull Bear: Why Alaunos Therapeutics Inc. stock is favored by pension funds2025 Trading Volume Trends & Weekly Watchlist of Top Performers - Улправда
Why Alaunos Therapeutics Inc. stock could see breakout soonJuly 2025 Review & Stepwise Trade Signal Guides - Улправда
Retail Surge: Will Alaunos Therapeutics Inc stock maintain dividend yield2025 Dividend Review & AI Forecasted Entry and Exit Points - moha.gov.vn
Will Alaunos Therapeutics Inc stock attract more institutional investorsM&A Rumor & Accurate Entry/Exit Alerts - moha.gov.vn
Alaunos Therapeutics reaches settlement with MD Anderson over unpaid invoices - Investing.com Canada
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer - TipRanks
Alaunos Therapeutics reaches settlement with MD Anderson over unpaid invoices By Investing.com - Investing.com South Africa
Risk Check: Can Alaunos Therapeutics Inc. stock outperform in 2025 bull market - Улправда
Will Alaunos Therapeutics Inc. stock maintain dividend yieldEarnings Growth Summary & Consistent Return Investment Signals - DonanımHaber
Will Alaunos Therapeutics Inc. stock split again soon2025 Trading Recap & Capital Protection Trade Alerts - DonanımHaber
Is Alaunos Therapeutics Inc. stock attractive after correctionWeekly Risk Report & Consistent Profit Trade Alerts - Улправда
How strong is Alaunos Therapeutics Inc. stock revenue growthSell Signal & Real-Time Chart Pattern Alerts - ulpravda.ru
Alaunos Therapeutics, Inc. (TCRT) Drops 6% in Pre-market: Trading Without a Clear Catalyst - Stocks Telegraph
Cell and gene therapy investment strategy pivots as funding dries up - Pharmaceutical Technology
Will Alaunos Therapeutics Inc. stock outperform growth indexesEarnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Will Alaunos Therapeutics Inc. stock recover faster than marketWeekly Trend Recap & Accurate Technical Buy Alerts - Newser
Is Alaunos Therapeutics Inc. stock a contrarian buy2025 Support & Resistance & Safe Entry Trade Signal Reports - Newser
What momentum indicators show for Alaunos Therapeutics Inc. stock2025 Institutional Moves & Real-Time Volume Analysis - Newser
Alaunos Therapeutics, Inc. (TCRT) 7.38% in After-hours: Momentum Builds Amid Routine Trading - Stocks Telegraph
Gilead snaps up Sprint’s TREX1 immunotherapy programme for $400m - Pharmaceutical Technology
Alaunos Therapeutics Inc. (TCRT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Alaunos Therapeutics Inc. stock ready for breakout2025 Fundamental Recap & High Accuracy Investment Signals - newser.com
What risks investors should watch in Alaunos Therapeutics Inc. stockWeekly Profit Summary & Low Risk High Win Rate Picks - newser.com
Is Alaunos Therapeutics Inc. stock cheap compared to fundamentalsRecession Risk & Verified High Yield Trade Plans - newser.com
Can you recover from losses in Alaunos Therapeutics Inc.CEO Change & Technical Confirmation Alerts - newser.com
Can Alaunos Therapeutics Inc. recover in the next quarterPortfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com
Risk adjusted return profile for Alaunos Therapeutics Inc. analyzedSell Signal & Safe Entry Momentum Tips - newser.com
Market reaction to Alaunos Therapeutics Inc.’s recent newsQuarterly Portfolio Review & Risk Controlled Daily Plans - newser.com
Alaunos Therapeutics, Inc.Common Stock (Nasdaq:TCRT) Stock Quote | User | woonsocketcall.com - Markets Financial Content
News impact scoring models applied to Alaunos Therapeutics Inc.2025 Bull vs Bear & Daily Volume Surge Signals - newser.com
Evaluating Alaunos Therapeutics Inc. with trendline analysisQuarterly Risk Review & Free Weekly Watchlist of Top Performers - newser.com
How to track smart money flows in Alaunos Therapeutics Inc.Earnings Overview Report & Consistent Return Strategy Ideas - newser.com
Why Alaunos Therapeutics Inc. stock could outperform in 20252025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Alaunos Therapeutics Inc (TCRT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):